|Bid||56.21 x 0|
|Ask||56.21 x 0|
|Day's Range||56.02 - 57.12|
|52 Week Range||31.81 - 76.68|
|Beta (3Y Monthly)||5.28|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
After recreational marijuana sales were legalized last year, Canopy Growth Corp.’s pot sales jumped 360%. When the world’s largest pot company reports a fresher crop of results this week, that number may be less than 40%.
Canopy Growth is making progress in the Australian market through its Spectrum Therapeutics brand, which caters to the demand for medical cannabis products. According to the company, the number of medical patients in the country has increased ten times in the last year.
New York has been on the fence about legalizing marijuana. In a series of tweets, New York City Mayor Bill De Blasio expressed strong support for legalizing cannabis the “RIGHT way.”
On June 18, Canopy Growth (WEED) (CGC) announced another international development: it has entered into an agreement with Procaps in Colombia. According to Canopy Growth, Procaps is active across the world, exporting its products to over 50 international markets.
On June 20, Canopy Growth (WEED) (CGC) is expected to report sales of 91.1 million Canadian dollars and a gross income of 24.4 million Canadian dollars. The company's margins are expected to compress.
On June 20, Canopy Growth (WEED) (CGC) is scheduled to announce its fourth-quarter and fiscal 2019 earnings after the market closes. The company's guidance will likely set the tone for the cannabis industry's near-term expectations.
Cannabis stocks are mixed, with market leader Canopy Growth Corp. gaining after it announced its latest growth moves ahead of Wednesday’s shareholder vote on its proposal to acquire Acreage Holdings.
Canopy said it will leverage Procaps’ encapsulation capacity. The Canopy subsidiary Spectrum Therapeutics has completed sales to patients in Chile and Brazil, the company said. In Australia, Spectrum received its first medical cannabis oil shipment in April, with sales commencing the following month.
The tech-heavy Nasdaq led the way early Monday. Top growth stock Lululemon is regaining a buy point in today's stock market action.
Last week was quite eventful for the cannabis industry, with Colorado reaching $1.0 billion in sales and Kroger Co (NYSE: KR ) announcing plans to start carrying CBD products. Here’s what you should keep ...
The sentiment towards the cannabis sector weakened further last week, as major industry players ended in the negative territory. HEXO (HEXO), which released disappointing earnings on June 12, was one of the key reasons for the extension of the weakness in the sector last week.
Lower-valued American cannabis stocks are set to outperform their Canadian rivals as U.S. legal pot sales outpace those north of the border.
Which stock wins in a battle between the biggest cannabis producer by market cap and the biggest supplier to the cannabis industry?
Medical marijuana and recreational marijuana are two high growth sectors in the cannabis industry. Learn about how the two differ, and how you can get into the market.
Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.
Operating results for the largest pot stock in the world are due out next week -- here's what you need to know.
Bluemercury co-founder Barry Beck says the company will be exploring CBD-infused products “in the next 24 months” as the cannabis beauty industry continues to boom.
Canadian cannabis company Canopy Growth Corp (NYSE: CGC) is weighing its options for non-equity financing as it looks to expand to take advantage of market opportunities in the United States and Europe. Possibilities for the company — the world’s largest cannabis firm — include setting up a real estate investment trust, as well as secured financing, the company’s new CFO Mike Lee told Bloomberg News in an interview. “We’re ... digesting the multiple options that we have in front of us, and comparing that to our business plans over the next few years,” Lee said.
The cannabis sector traded mostly lower Tuesday, with the ETFMG Alternative Harvest ETF down 1.0% as 24 of 38 components traded lower. The Horizons Marijuana Life Sciences Index ETF dropped 1.4%, with 43 of 57 components falling. The declines come the ETFMG ETF gained 4.6% and the Horizons ETF advanced 5.5% over the past two sessions, while the S&P 500 tacked on 1.5%. Among some of the more-active pot stocks, Aurora Cannabis Inc. fell 2.6%, Canopy Growth Corp. shed 2.1%, Cronos Group Inc. gave up 2.5%, Tilray Inc. slumped 5.3% and Canopy Rivers Inc. lost 1.4%. The ETFMG ETF has now lost 10.3% over the past three months, while the S&P 500 has gained 3.7%.
If you have doubts that cannabis is on its way from illegal to industrial, take a look inside Cresco Labs’ custom built, 43-thousand square-foot production facility in Joliet, Illinois.